Lactulose for the Prevention of Hepatic Encephalopathy in Cirrhotic Patients With Upper Gastrointestinal Hemorrhage

NCT00553423 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

128

Enrollment

OTHER

Sponsor class

Conditions

Hepatocerebral Encephalopathy
Portal-Systemic Encephalopathy
Encephalopathy, Hepatic
Encephalopathy, Hepatocerebral

Interventions

DRUG: Lactulose
DRUG: Placebo

Sponsor

Aga Khan University